Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4
- PMID: 21068404
- DOI: 10.4049/jimmunol.1001876
Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4
Abstract
Regulatory T cells (Tregs) are thought to facilitate tumor development by suppressing protective antitumor immune responses. However, recent clinical and laboratory studies show that Tregs are a favorable element against cancer. In this study, we provide evidence that Tregs have both promoting and inhibiting effects on tumors, depending on the stage of tumor development. By using 0.5 mg cyclophosphamide, we constructed a murine liver cancer model in which Tregs were continuously and selectively depleted. Under such conditions, we found that tumor growth was inhibited at early stages but accelerated later on. Analysis of the tumor microenvironment disclosed that long-term Treg depletion by 0.5 mg cyclophosphamide treatment induced Gr-1(+)CD11b(+) myeloid-derived suppressor cells (MDSCs). Ablation of MDSCs by anti-Gr-1 Ab blocked Treg depletion-induced promotion of tumor growth. Furthermore, lipoxygenases 5 and 12, two enzymes participating in the biosynthesis of the lipid anti-inflammatory mediator lipoxin A(4), were upregulated or downregulated by Treg depletion or adoptive transfer. Correspondingly, the levels of lipoxin A(4) were increased or decreased. Lipoxin A(4) thus regulated the induction of MDSCs in response to Treg depletion. These findings suggest that Tregs may play different roles at different stages of tumor growth: promoting early and inhibiting late tumor growth. Our study also suggests that the interplay among Tregs, MDSCs, and lipoxin A(4) tunes the regulation of tumor-associated inflammation.
Similar articles
-
Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after Urethane-induced lung tumor.Int Immunopharmacol. 2011 Jul;11(7):873-8. doi: 10.1016/j.intimp.2010.12.025. Epub 2011 Jan 14. Int Immunopharmacol. 2011. PMID: 21238620
-
Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.Cancer Res. 2010 Apr 1;70(7):2665-74. doi: 10.1158/0008-5472.CAN-09-1574. Epub 2010 Mar 23. Cancer Res. 2010. PMID: 20332236
-
CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.J Immunol. 2010 Jul 1;185(1):203-10. doi: 10.4049/jimmunol.0903573. Epub 2010 Jun 4. J Immunol. 2010. PMID: 20525890
-
T regulatory cells in cancer: recent advances and therapeutic potential.Expert Opin Biol Ther. 2010 Nov;10(11):1573-86. doi: 10.1517/14712598.2010.529126. Expert Opin Biol Ther. 2010. PMID: 20955112 Review.
-
Myeloid derived suppressor cells and their role in tolerance induction in cancer.J Dermatol Sci. 2010 Jul;59(1):1-6. doi: 10.1016/j.jdermsci.2010.05.001. J Dermatol Sci. 2010. PMID: 20570112 Review.
Cited by
-
The influence of Cox-2 and bioactive lipids on hematological cancers.Curr Angiogenes. 2013 Sep 1;2(2):135-142. doi: 10.2174/2211552802999140131105947. Curr Angiogenes. 2013. PMID: 24883266 Free PMC article.
-
Good news-bad news: the Yin and Yang of immune privilege in the eye.Front Immunol. 2012 Nov 27;3:338. doi: 10.3389/fimmu.2012.00338. eCollection 2012. Front Immunol. 2012. PMID: 23230433 Free PMC article.
-
Carcinogenesis: Failure of resolution of inflammation?Pharmacol Ther. 2021 Feb;218:107670. doi: 10.1016/j.pharmthera.2020.107670. Epub 2020 Sep 3. Pharmacol Ther. 2021. PMID: 32891711 Free PMC article. Review.
-
New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation.Front Immunol. 2012 Jan 31;3:4. doi: 10.3389/fimmu.2012.00004. eCollection 2012. Front Immunol. 2012. PMID: 22566890 Free PMC article.
-
The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression.Cancers (Basel). 2022 Jul 8;14(14):3333. doi: 10.3390/cancers14143333. Cancers (Basel). 2022. PMID: 35884394 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials